InspireMD EBITDA Margin 2013-2025 | NSPR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for InspireMD (NSPR) over the last 10 years. The current EBITDA margin for InspireMD as of March 31, 2025 is .
| InspireMD EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.01B | $-0.04B | -450.00% |
| 2024-12-31 | $0.01B | $-0.03B | -400.00% |
| 2024-09-30 | $0.01B | $-0.03B | -362.50% |
| 2024-06-30 | $0.01B | $-0.03B | -337.50% |
| 2024-03-31 | $0.01B | $-0.02B | -300.00% |
| 2023-12-31 | $0.01B | $-0.02B | -300.00% |
| 2023-09-30 | $0.01B | $-0.02B | -333.33% |
| 2023-06-30 | $0.01B | $-0.02B | -380.00% |
| 2023-03-31 | $0.01B | $-0.02B | -380.00% |
| 2022-12-31 | $0.01B | $-0.02B | -380.00% |
| 2022-09-30 | $0.01B | $-0.02B | -360.00% |
| 2022-06-30 | $0.01B | $-0.02B | -340.00% |
| 2022-03-31 | $0.00B | $-0.02B | -375.00% |
| 2021-12-31 | $0.00B | $-0.01B | -350.00% |
| 2021-09-30 | $0.00B | $-0.01B | -466.67% |
| 2021-06-30 | $0.00B | $-0.01B | -400.00% |
| 2021-03-31 | $0.00B | $-0.01B | -550.00% |
| 2020-12-31 | $0.00B | $-0.01B | -500.00% |
| 2020-09-30 | $0.00B | $-0.01B | -266.67% |
| 2020-06-30 | $0.00B | $-0.01B | -266.67% |
| 2020-03-31 | $0.00B | $-0.01B | -200.00% |
| 2019-12-31 | $0.00B | $-0.01B | -300.00% |
| 2019-09-30 | $0.00B | $-0.01B | -300.00% |
| 2019-06-30 | $0.00B | $-0.01B | -300.00% |
| 2019-03-31 | $0.00B | $-0.01B | -266.67% |
| 2018-12-31 | $0.00B | $-0.01B | -175.00% |
| 2018-09-30 | $0.00B | $-0.01B | -150.00% |
| 2018-06-30 | $0.00B | $-0.01B | -150.00% |
| 2018-03-31 | $0.00B | $-0.01B | -175.00% |
| 2017-12-31 | $0.00B | $-0.01B | -175.00% |
| 2017-09-30 | $0.00B | $-0.01B | -266.67% |
| 2017-06-30 | $0.00B | $-0.01B | -400.00% |
| 2017-03-31 | $0.00B | $-0.01B | -400.00% |
| 2016-12-31 | $0.00B | $-0.01B | -400.00% |
| 2016-09-30 | $0.00B | $-0.01B | -300.00% |
| 2016-06-30 | $0.00B | $-0.01B | -250.00% |
| 2016-03-31 | $0.00B | $-0.01B | -300.00% |
| 2015-12-31 | $0.00B | $-0.02B | -500.00% |
| 2015-09-30 | $0.00B | $-0.02B | -533.33% |
| 2015-06-30 | $0.00B | $-0.02B | -950.00% |
| 2015-03-31 | $0.00B | $-0.02B | -2200.00% |
| 2014-12-31 | $0.00B | $-0.02B | -1100.00% |
| 2014-06-30 | $0.00B | $-0.02B | -533.33% |
| 2014-03-31 | $0.01B | $-0.01B | -260.00% |
| 2013-06-30 | $0.01B | $-0.01B | -200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.068B | $0.007B |
| InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.825B | 84.46 |
| Thermo Fisher Scientific (TMO) | United States | $159.102B | 19.25 |
| Edwards Lifesciences (EW) | United States | $45.274B | 29.68 |
| Alcon (ALC) | Switzerland | $43.909B | 29.67 |
| IDEXX Laboratories (IDXX) | United States | $43.641B | 50.15 |
| DexCom (DXCM) | United States | $32.772B | 50.65 |
| IQVIA Holdings (IQV) | United States | $28.132B | 15.76 |
| Mettler-Toledo (MTD) | United States | $25.049B | 29.79 |
| STERIS (STE) | Ireland | $23.871B | 26.29 |
| Waters (WAT) | United States | $21.247B | 29.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.939B | 0.00 |
| Hologic (HOLX) | United States | $14.558B | 15.82 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.708B | 76.19 |
| Masimo (MASI) | United States | $9.164B | 33.80 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.858B | 0.00 |
| Teleflex (TFX) | United States | $5.384B | 8.89 |
| TransMedics (TMDX) | United States | $4.401B | 95.66 |
| Integer Holdings (ITGR) | United States | $4.232B | 22.17 |
| PROCEPT BioRobotics (PRCT) | United States | $3.130B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.85 |
| Nihon Kohden (NHNKY) | Japan | $2.305B | 26.43 |
| Veracyte (VCYT) | United States | $2.140B | 30.02 |
| Elekta AB (EKTAY) | Sweden | $1.918B | 17.24 |
| Alphatec Holdings (ATEC) | United States | $1.598B | 0.00 |
| Artivion (AORT) | United States | $1.313B | 123.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.030B | 5.48 |
| Pulse Biosciences (PLSE) | United States | $0.998B | 0.00 |
| SiBone (SIBN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.04 |
| Beta Bionics (BBNX) | United States | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.579B | 9.01 |
| RxSight (RXST) | United States | $0.533B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.533B | 12.49 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.395B | 10.51 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.379B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.44 |